For a 19‑year‑old patient with type 1 diabetes weighing 86.2 kg who is currently taking insulin glargine (Lantus) 12 U at 08:00 and 35 U at 20:00 and uses insulin‑to‑carbohydrate ratios of 1 U per 5 g carbs for breakfast and lunch and 1 U per 6 g carbs for dinner, what should the basal Lantus dose and insulin‑to‑carbohydrate ratio be adjusted to?

Basal Insulin and ICR Adjustment Recommendations

Based on this patient's blood glucose pattern showing persistent hyperglycemia throughout the day (293 mg/dL at 11 am, 253 mg/dL at 5 pm, 219 mg/dL at 9 pm) despite adequate overnight control (146 mg/dL at 4 am), I recommend increasing the morning Lantus dose from 12 units to 18-20 units while keeping the evening dose at 35 units, and tightening all insulin-to-carbohydrate ratios to 1:4 for breakfast/lunch and 1:5 for dinner.

Analysis of Current Glucose Pattern

The blood glucose data reveals several critical issues:

• Morning hyperglycemia (293 mg/dL at 11 am) after only 12g carbs at breakfast indicates inadequate daytime basal coverage and/or insufficient breakfast bolus
• Afternoon rise (186→253 mg/dL) between 3 pm and 5 pm suggests daytime basal insulin insufficiency
• Overnight control is acceptable (219→146 mg/dL), indicating the evening Lantus dose of 35 units is appropriate
• The 4 am glucose of 146 mg/dL confirms no nocturnal hypoglycemia risk

Basal Insulin (Lantus) Dose Adjustments

Morning Lantus Dose

Increase from 12 units to 18-20 units at 8 am 1, 2

The current total daily basal dose is 47 units (12 + 35). For an 86.2 kg patient, this represents approximately 0.55 units/kg/day of basal insulin alone. The ADA guidelines recommend starting basal insulin at 0.1-0.2 units/kg/day and titrating upward 1. Given the persistent daytime hyperglycemia without nocturnal hypoglycemia, the morning dose requires a 50% increase (6-8 units).

Rationale: The blood glucose rises from 186 mg/dL at 3 pm to 253 mg/dL at 5 pm, demonstrating inadequate afternoon basal coverage. Since Lantus administered in the morning provides peak action during the afternoon and evening hours 2, increasing the morning dose will address this specific pattern. The FDA label data shows that maximum blood glucose occurs just prior to the next Lantus injection 2, which explains the pre-dinner hyperglycemia.

Evening Lantus Dose

Maintain at 35 units at 8 pm

The overnight glucose control (219→146 mg/dL) demonstrates adequate basal coverage during sleep without hypoglycemia. The 4 am glucose of 146 mg/dL is acceptable and safe 3, 4.

Insulin-to-Carbohydrate Ratio Adjustments

Current Problem

The 11 am glucose of 293 mg/dL after eating only 12g carbs at 8 am (which should have required 2.4 units at 1:5 ratio) indicates the breakfast ICR is too weak.

Recommended ICR Changes

Breakfast: Change from 1:5 to 1:4

• This represents a 25% increase in breakfast bolus insulin
• For 12g carbs, the patient would now receive 3 units instead of 2.4 units

Lunch: Change from 1:5 to 1:4

• Maintains consistency with breakfast dosing
• Addresses the afternoon hyperglycemia pattern

Dinner: Change from 1:6 to 1:5

• This represents a 20% increase in dinner bolus insulin
• For 90g carbs, the patient would now receive 18 units instead of 15 units
• The post-dinner glucose of 219 mg/dL (down from 253 mg/dL pre-dinner) suggests the current dinner ratio is close but needs tightening

Titration Algorithm

Following ADA guidelines 1:

1. Increase morning Lantus by 2 units every 3 days until afternoon/pre-dinner glucose reaches 120-180 mg/dL without hypoglycemia
2. If hypoglycemia occurs: Reduce the corresponding dose by 10-20% 1
3. Monitor pre-meal and 2-hour post-meal glucose to assess ICR effectiveness
4. Adjust ICR if post-meal glucose consistently exceeds target by 50+ mg/dL above pre-meal value 1

Critical Safety Considerations

Hypoglycemia Risk

• The patient currently shows no evidence of hypoglycemia (lowest recorded glucose is 146 mg/dL)
• Research demonstrates that Lantus reduces nocturnal hypoglycemia compared to NPH insulin 3, 4
• Monitor for hypoglycemia between midnight and 4 am if evening dose is adjusted 5

Timing Flexibility

The FDA label confirms that Lantus can be administered at different times of day with similar efficacy 2. The current twice-daily split dosing (8 am and 8 pm) is appropriate and should be maintained. Studies show that blood glucose rises around the time of Lantus injection regardless of timing 6, which explains the pre-dinner hyperglycemia pattern.

Insulin Sensitivity Factor (ISF)

The current ISF of 25 mg/dL per unit appears reasonable but should be reassessed after basal optimization. The correction dose calculation should use the formula: (Current BG - Target BG) ÷ ISF 1.

Implementation Steps

1. Week 1: Increase morning Lantus to 18 units, implement new ICRs (1:4,1:4,1:5)
2. Week 2: If afternoon glucose remains >180 mg/dL, increase morning Lantus to 20 units
3. Week 3: Reassess all parameters; fine-tune ICRs based on post-prandial patterns
4. Ongoing: Monitor for hypoglycemia; reduce doses by 10-20% if unexplained hypoglycemia occurs 1

The total daily insulin dose will increase from approximately 47 units basal + bolus insulin to approximately 53-55 units basal + increased bolus coverage, which remains appropriate for this patient's weight and glycemic needs 1, 2.